Genome-wide analyses of Zta binding to the epstein-barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile

Journal of Virology

Volumn 86, Issue 23, 2012, Pages 12494-12502

  Ramasubramanyan, Sharada ^a   Kanhere, Aditi ^b,c   Osborn, Kay ^a   Flower, Kirsty ^a   Jenner, Richard G ^b   Sinclair, Alison J ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN BZLF1; VIRUS DNA;

ARTICLE; BINDING AFFINITY; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA METHYLATION; DNA REPLICATION; DNA RESPONSIVE ELEMENT; DNA SEQUENCE; EPSTEIN BARR VIRUS; GENE LOCUS; GENE SWITCHING; GENETIC ASSOCIATION; GENETIC EPIGENESIS; GENOME ANALYSIS; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; VIRUS GENOME; VIRUS REPLICATION;

BINDING SITES; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DNA PRIMERS; EPIGENESIS, GENETIC; GENOME, VIRAL; GENOMICS; HERPESVIRUS 4, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; PROTEIN BINDING; TRANS-ACTIVATORS; VIRUS REPLICATION;

EQUUS SUBG. HIPPOTIGRIS; HUMAN HERPESVIRUS 4;

EID: 84869208972     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01705-12     Document Type: Article

References (45)

1. Amon W, et al. 2004. Lytic cycle gene regulation of Epstein-Barr virus. J. Virol. 78:13460-13469.
2. Bark-Jones SJ, Webb HM, West MJ. 2006. EBV EBNA 2 stimulates CDK9-dependent transcription and RNA polymerase II phosphorylation on serine 5. Oncogene 25:1775-1785.
3. Bergbauer M, et al. 2010. CpG-methylation regulates a class of Epstein-Barr virus promoters. PLoS Pathog. 6:e1001114. doi:10.1371/ journal.ppat.1001114.
4. Bhende PM, Seaman WT, Delecluse HJ, Kenney SC. 2004. The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat. Genet. 36:1099-1104.
5. Bird AP, Wolffe AP. 1999. Methylation-induced repression- belts, braces, and chromatin. Cell 99:451-454.
6. Cohen JI. 2000. Epstein-Barr virus infection. N. Engl. J. Med. 343:481-492.
7. Dickerson SJ, et al. 2009. Methylation-dependent binding of the Epstein-Barr virus BZLF1 protein to viral promoters. PLoS Pathog. 5:e1000356. doi:10.1371/journal.ppat.1000356.
8. Farrell PJ. 2005. Epstein-Barr virus genome, p 263-287. In Robertson ES (ed), Epstein-Barr virus. Caister Academic Press, Wymondham, United Kingdom.
9. Feederle R, et al. 2000. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 19:3080-3089.
10. Fernandez AF, et al. 2009. The dynamic DNA methylomes of doublestranded DNA viruses associated with human cancer. Genome Res. 19: 438-451.
11. Flower K, et al. 2011. Epigenetic control of viral life-cycle by a DNAmethylation dependent transcription factor. PLoS One 6:e25922. doi: 10.1371/journal.pone.0025922.
12. Gallagher A, et al. 1999. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. Int. J. Cancer 84:442-448.
13. Gruffat H, Kadjouf F, Mariame B, Manet E. 2012. The Epstein-Barr virus BcRF1 gene product is a TBP-like protein with an essential role in late gene expression. J. Virol. 86:6023-6032.
14. Halder S, et al. 2009. Early events associated with infection of Epstein-Barr virus infection of primary B-cells. PLoS One 4:e7214. doi:10.1371/ journal.pone.0007214.
15. Heather J, Flower K, Isaac S, Sinclair AJ. 2009. The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1. J. Gen. Virol. 90:1450-1454.
16. Hong GK, et al. 2005. Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines. J. Virol. 79:13984-13992.
17. Israel B, Kenney SC. 2005. EBV lytic infection, p 571-611. In Robertson ES (ed), Epstein-Barr virus. Caister Academic Press, Wymondham, United Kingdom.
18. Jones RJ, et al. 2007. Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease. Int. J. Cancer 121:1274-1281.
19. Kalla M, Schmeinck A, Bergbauer M, Pich D, Hammerschmidt W. 2010. AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proc. Natl. Acad. Sci. U. S. A. 107:850-855.
20. Karlsson QH, Schelcher C, Verrall E, Petosa C, Sinclair AJ. 2008. Methylated DNA recognition during the reversal of epigenetic silencing is regulated by cysteine and serine residues in the Epstein-Barr virus lytic switch protein. PLoS Pathog. 4:e1000005. doi:10.1371/journal. ppat.1000005.
21. Karlsson QH, Schelcher C, Verrall E, Petosa C, Sinclair AJ. 2008. The reversal of epigenetic silencing of the EBV genome is regulated by viral bZIP protein. Biochem. Soc. Trans. 36:637-639.
22. Klose RJ, Bird AP. 2006. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31:89-97.
23. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10:R25.
24. Ma SD, et al. 2011. A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J. Virol. 85:165-177.
25. Macsween KF, Crawford DH. 2003. Epstein-Barr virus-recent advances. Lancet Infect. Dis. 3:131-140.
26. Miller G. 1989. The switch between EBV latency and replication. Yale J. Biol. Med. 62:205-213.
27. Miller IG, Jr, El-Guindy A. 2002. Regulation of Epstein-Barr virus lytic cycle activation in malignant and nonmalignant disease. J. Natl. Cancer Inst. 94:1733-1735.
28. Murray PG, Young LS. 2001. Epstein-Barr virus infection: basis of malignancy and potential for therapy. Expert Rev. Mol. Med. 3(28):1-20.
29. Petosa C, et al. 2006. Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein. Mol. Cell 21:565-572.
30. Ragoczy T, Miller G. 1999. Role of the Epstein-Barr virus Rta protein in activation of distinct classes of viral lytic cycle genes. J. Virol. 73:9858-9866.
31. Ramasubramanyan S, Osborn K, Flower K, Sinclair AJ. 2012. Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome. J. Virol. 86:1809-1819.
32. Rishi V, et al. 2010. CpG methylation of half-CRE sequences creates C/EBPα binding sites that activate some tissue-specific genes. Proc. Natl. Acad. Sci. U. S. A. 107:20311-20316.
33. Rowe M, Kelly GL, Bell AI, Rickinson AB. 2009. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Semin. Cancer Biol. 19:377-388.
34. Saha A, Robertson ES. 2011. Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes. Clin. Cancer Res. 17:3056-3063.
35. Shannon-Lowe C, et al. 2009. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J. Virol. 83:7749-7760.
36. Sinclair AJ. 2006. Unexpected structure of Epstein-Barr virus lytic cycle activator Zta. Trends Microbiol. 14:289-291.
37. Sinclair AJ, Farrell PJ. 1992. Epstein-Barr virus transcription factors. Cell Growth Differ. 3:557-563.
38. Takada K. 1984. Cross-linking of surface immunoglobulins induces Epstein-Barr virus in Burkitt's lymphoma cell lines. Int. J. Cancer 33:27-32.
39. Thorley-Lawson DA. 2001. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1:75-82.
40. Thorley-Lawson DA, Allday MJ. 2008. The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat. Rev. Microbiol. 6:913-924.
41. Tierney RJ, et al. 2000. Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation. J. Virol. 74:10468-10479.
42. Wang FZ, et al. 2009. Maribavir inhibits Epstein-Barr virus transcription in addition to viral DNA replication. J. Virol. 83:12108-12117.
43. Yin Q, Jupiter K, Flemington EK. 2004. The Epstein-Barr virus transactivator Zta binds to its own promoter and is required for full promoter activity during anti-Ig and TGF-β1 mediated reactivation. Virology 327: 134-143.
44. Young LS, et al. 1991. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J. Virol. 65:2868-2874.
45. Yuan J, Cahir-McFarland E, Zhao B, Kieff E. 2006. Virus and cell RNAs expressed during Epstein-Barr virus replication. J. Virol. 80:2548-2565.